======= SARDH =======
== Gene Information ==
* **Official Symbol**: SARDH
* **Official Name**: sarcosine dehydrogenase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1757|1757]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UL12|Q9UL12]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SARDH&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SARDH|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604455|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes an enzyme localized to the mitochondrial matrix which catalyzes the oxidative demethylation of sarcosine. This enzyme is distinct from another mitochondrial matrix enzyme, dimethylglycine dehydrogenase, which catalyzes a reaction resulting in the formation of sarcosine. Mutations in this gene are associated with sarcosinemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Oct 2008].
* **UniProt Summary**: N/A
|GCV T C|
|GCV T|
|DAO|
|sarcosine catabolic process|
|sarcosine dehydrogenase activity|
|sarcosine metabolic process|
|choline catabolic process|
|choline metabolic process|
|amine catabolic process|
|cellular biogenic amine catabolic process|
|neurotransmitter catabolic process|
|cellular modified amino acid catabolic process|
|cellular biogenic amine metabolic process|
|cellular amine metabolic process|
|amine metabolic process|
|neurotransmitter metabolic process|
|alpha-amino acid catabolic process|
|oxidoreductase activity|
|cellular amino acid catabolic process|
|ammonium ion metabolic process|
|cellular modified amino acid metabolic process|
|alpha-amino acid metabolic process|
|carboxylic acid catabolic process|
|organic acid catabolic process|
|cellular amino acid metabolic process|
|regulation of neurotransmitter levels|
|mitochondrial matrix|
|small molecule catabolic process|
|carboxylic acid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|organic acid metabolic process|
|organonitrogen compound catabolic process|
|mitochondrion|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp492|iCRT14 30μM R08 exp492]]|-1.95|
|[[:results:exp391|Pomalidomide 20μM R07 exp391]]|-1.78|
|[[:results:exp96|BI-2536 0.02μM R03 exp96]]|1.93|
|[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.3|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4827
* **Expression level (log2 read counts)**: 3.61
{{:chemogenomics:nalm6 dist.png?nolink |}}